Abstract
Corrigendum to, Is the patient’s baseline inhaled steroid dose a factor for choosing the budesonide/formoterol maintenance and reliever therapy regimen?, published in volume 5, issue 5 of Therapeutic Advances in Respiratory Disease [1].
Subject
Pharmacology (medical),Pulmonary and Respiratory Medicine